CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE
On Demand Web ArchiveNon-Accredited
Target Audience: Physicians, nurses, and technologists.
This activity is supported by an educational grant from Terumo Medical Corporation.
Original Contribution
Do Bifurcated Endografts Produce Better Outcomes than Aorto-Uni-Iliac Designs in Endovascular Aneurysm Repair?
Author Affiliations:
From the 1Hospital Clinic of Barcelona, Barcelona, Spain and 2Eurostar Data Registry Center, Catharina Hospital, Eindhoven, The Netherlands.
Correspondence: Vincent Riambau, MD, Hospital Clinic of Barcelona, Vascular Surgery, Villarroel 170, Barcelona, Spain 08036. E-mail: riambau@meditex.ese.
Manuscript submitted August 24, 2008, provisional acceptance given September 30, accepted October 20, 2008.
Disclosure: The authors report no financial relationship or conflicts of interest regarding the content therein.
The Potential Role of Iloprost as Adjuvant to Surgery for Acute Limb Ischemia: Findings from the ILAILL Study
1Gianmarco de Donato, MD, 2Gualberto Gussoni, MD, 1Carlo Setacci, MD, 3Gaetano de Donato, MD; on behalf of @the ILAILL Study Group
Author Affiliations:
From the 1Department of Surgery, Vascular and Endovascular Surgery Unit, University of Siena; 2FADOI Study Center, Roma; 3Department of Surgery, Vascular Surgery Unit, San Giovanni Bosco Hospital, II University of Naples, Italy.
@The ILAILL Study Group participants are listed in the Appendix.
Percutaneous Mechanical Thrombectomy of Acute Lower Extremity Ischemia
Abstract
Background. Data are limited regarding the efficacy of percutaneous mechanical thrombectomy (PMT) for the treatment of acute lower extremity (LE) ischemia. The current study was undertaken to evaluate the results following PMT for occluded LE bypass grafts, stents, and thromboembolic events involving native arteries. Methods. During a 3-year period, 43 patients underwent PMT. The patient’s outcome, including the technical success rate, additional procedures, major complications, limb salvage rate, and length of hospital stay were documented for each patient. Ultrasound fol
Percutaneous Creation of Arteriovenous Shunts
Abstract
Reductions in systemic vascular resistance and increased cardiac output are thought to help maintain tissue oxygen delivery during hypoxia. Here we discuss the rationale for creating arteriovenous (AV) shunts in humans and we describe novel techniques for percutaneous creation of AV shunts in patients. Although large AV shunts have been associated with cardiac failure, we believe that the creation of a moderate arteriovenous fistula (AVF) might benefit selected patients with respiratory disease. Here we study the acute effects of an AVF on mixed venous oxygen content and ar
Early Clinical Experience with a Novel, Self-Centering, Bi-Directional Vena Cava Filter
Introduction
Pulmonary emboli (PE) are estimated to be the third leading cause of cardiovascular death in the United States. Over 600,000 cases are reported in the US annually, causing an estimated 120,000 to 150,000 deaths per year. Emboli most commonly arise from pre-existing deep venous thromboses (DVT). While anticoagulation remains the gold standard of care for both DVT and PE, many patients are contraindicated for anticoagulation1 and up to one-third of PE occurs in patients already on anticoagulant therapy.
Caval interruption by placement of an inferior vena cava
Rotational Atherectomy to Enable Sirolimus-Eluting Stent Implantation in Calcified, Nondilatable De Novo Coronary Artery Lesio
The sirolimus-eluting stent (SES) has demonstrated its angiographic and clinical efficacy in the suppression of coronary neointimal hyperplasia in a number of randomized clinical trials.1–7 Observational studies have supported the trial results in patient and lesion subsets that were excluded from these trials.8–14 The common denominator of all studies to date is that the targeted lesions were not subjected to any pretreatment other than predilatation. In particular, nondilatable calcified lesions were excluded from clinical trials and, to date, have not been studied
Improving Critical Limb Ischemia Outcomes with Novel Anticoagulation Strategies
I believe the authors are on the right track by exploring more optimal anticoagulation and antiplatelet strategies in treating patients with peripheral arterial disease (PAD), and especially critical limb ischemia (CLI). The limitations and bleeding complications with unfractionated heparin (UFH) have been well documented during percutaneous coronary intervention (PCI), and likewise over the last several years during percutaneous peripheral intervention (PPI).1,2 The PAD patients, and especially the CLI patients, are at significantly higher risks for all hemorrhagic and thrombotic c
Use of a Disposable Radiation Protective Table for Reducing Operator Radiation Exposure during Cardiovascular Angiographic Proce
Introduction
The use of fluoroscopic imaging continues to increase during medical procedures. Fluoroscopic imaging plays a fundamental role in the diagnostic and treatment of cardiac and vascular disease. The cumulative operator and/or staff occupational exposure from scatter radiation may be considerable.1 Cardiologists are the most common physician specialty with overexposure to radiation, and the number is felt to be grossly underreported.2 The risk of these exposures may not be appreciated by physicians because the adverse consequence is not immediate. Though
Catheter-Directed Thrombolysis and Percutaneous Thrombectomy for Acute Arterial Ischemia in Children
Introduction
Acute arterial ischemia is defined as the sudden decrease in blood flow to a tissue bed due to an embolism or thrombosis, resulting in a potential threat to the viability of the area.1 The intravascular administration of thrombolytic agents originated in the 1960s for the treatment of pulmonary embolism. Thrombolysis by selective catheter infusion for vascular occlusion entered the mainstream during the 1970s.2 Thrombolytic agents have been successfully employed to dissolve the occluding thrombus, reconstitute blood flow and improve the status of the
Endoscopic Vein Harvest for Infrainguinal Vascular Reconstruction and Limb Salvage in Chronic Critical Limb Ischemia
Introduction
Autogenous greater saphenous vein is the preferred conduit for infrainguinal vascular reconstruction, and the most commonly utilized venous conduit for coronary artery bypass grafting. Harvesting for these procedures has traditionally utilized a longitudinal continuous saphenectomy incision. Wound problems can be significant with this approach and bridging techniques evolved to lessen this complication.1–5 Endoscopic vein harvesting (EVH) was introduced in the 1990s and has now become the preferred method for greater saphenous vein harvesting in coronary arter
Digital Supplements Using Advanced Technology to |
 Superior Mesenteric Artery Revascularization and |
Vascular Disease News Wire
- Thursday, December 11, 2008 - 16:23
- Monday, November 24, 2008 - 11:56
- Monday, October 6, 2008 - 10:02
Anytown, California
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
 LUMEN 2009 - THE SYMPOSIUM ON OPTIMAL TREATMENTS FOR ACUTE MI Live Symposium Date: February 26-28 Location: Loews Miami Beach Hotel Miami Beach, Florida 33139 Phone: (305) 604-1601 Toll Free: 1-877-563-9762 This activity is sponsored by the North American Center for Continuing Medical Education. |
 CARDIAC PET: Optimizing CAD Patient Management with Diagnostic Confidence A Complimentary CME Accredited Lunch Symposium Date: Friday, September 12, 2008 12:00 pm - 1:15 pm Location: Hynes Convention Center 900 Boylston Street, Room 304 Boston, MA 02115 This activity is supported by an educational grant from Bracco Diagnostics Inc. |
REVIEW OUR OTHER
CARDIOLOGY BRANDS
Check out our other resources for healthcare professionals of all specialties.
